2 Stocks Down 74% and 57.5% to Buy Right Now
https://www.fool.com/investing/2024/07/02/2-stocks-down-74-and-575-to-buy-right-now/?source=iedfolrf0000001
Jul 02, 2024 - Taking a buy-and-hold approach with these beaten-down stocks could reward investors with market-crushing returns.
0
Here's Why You Should Retain Ensign Group (ENSG) Stock Now
https://www.zacks.com/stock/news/2296347/here-s-why-you-should-retain-ensign-group-ensg-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296347
Jul 02, 2024 - Ensign Group (ENSG) remains well-poised for growth on the back of solid segmental contributions, an expanding healthcare portfolio and sound cash reserves.
0
Peloton staved off the cash crunch that threatened its business. Where does it go now?
https://www.cnbc.com/2024/07/02/peloton-staves-off-liquidity-crunch-in-global-refinance.html
Jul 02, 2024 - Peloton's looming debt pile raised concerns that the company could be pushed into bankruptcy. Now that Peloton has refinanced, it still has to fix its strategy.
0
Reasons to Add Entergy (ETR) to Your Portfolio Right Now
https://www.zacks.com/stock/news/2296349/reasons-to-add-entergy-etr-to-your-portfolio-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296349
Jul 02, 2024 - Entergy (ETR) makes a strong case for investment, given its earnings growth prospects, strong ROE and increasing consumer demand.
0
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2296273/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296273
Jul 02, 2024 - PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
0
Reasons Why Fiserv (FI) Stock is an Attractive Pick for Now
https://www.zacks.com/stock/news/2296239/reasons-why-fiserv-fi-stock-is-an-attractive-pick-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296239
Jul 02, 2024 - Fiserv (FI) benefits from its business model, client addition and retention, and providing value-added solutions to its clients.
0
Reasons to Hold Axon Enterprise (AXON) in Your Portfolio Now
https://www.zacks.com/stock/news/2296090/reasons-to-hold-axon-enterprise-axon-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|zer_report_update-2296090
Jul 02, 2024 - Axon Enterprise (AXON) gains from strength across its businesses, product introductions and complementary acquisitions. Rising costs and expenses may hurt its profitability.
0
1 Growth Stock Down 56% to Buy Right Now
https://www.fool.com/investing/2024/07/02/1-growth-stock-down-56-to-buy-right-now/?source=iedfolrf0000001
Jul 02, 2024 - Check out a tech company making strategic moves for future success. This hidden AI gem comes with fantastic growth prospects.
0
Here's Why You Should Retain FedEx (FDX) Stock for Now
https://www.zacks.com/stock/news/2296105/here-s-why-you-should-retain-fedex-fdx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296105
Jul 02, 2024 - FedEx's (FDX) bottom line is bolstered by reduced structural cost initiatives. Efforts to reward shareholders are commendable. However, FedEx grapples with geopolitical uncertainties and higher inflation.
0
Here's Why Alexandria (ARE) is an Apt Portfolio Pick for Now
https://www.zacks.com/stock/news/2296127/here-s-why-alexandria-are-is-an-apt-portfolio-pick-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296127
Jul 02, 2024 - Robust demand for Alexandria's (ARE) high-quality life science and lab office properties in key markets, healthy operating performance and expansion efforts bode well for long-term growth.
0